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Abstract
One in 150 infants is born with cytomegalovirus (CMV) and one in 750 will have lifelong disabilities due to CMV. Even though congenital CMV is the 
leading viral cause of congenital disabilities and the leading non-genetic cause of childhood hearing loss, most adults have never heard of it. Data from 
the 2015 and 2016 HealthStylesTM surveys were analyzed and compared to data from similar studies and show an awareness rate of 7% for U.S. adults 
(5% for men and 9% for women), a statistically significant decrease from 2005 and 2010 HealthStylesTM  surveys. Predictors of awareness include 
gender and education level. The presence of a child ages 0–5 in the household does not increase the chance that an adult in the household is aware of 
CMV. CMV is a large public health burden and further research needs to be focused on awareness and prevention of the negative sequela associated 
with congenital CMV. 
Acronyms: CDC = Centers for Disease Control and Prevention, CMV = Cytomegalovirus, IOM = Institutes of Medicine (now known as National Academies of Sciences, 
Engineering, and Medicine), STD = Sexually Transmitted Disease
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Cytomegalovirus (CMV) is a member of the herpes family 
of viruses, spread through bodily fluids including saliva, 
blood, genital secretions, urine, and breast milk. Ninety 
percent of the U.S. population has had CMV by the time 
they are 80 years old and most do not experience any 
symptoms (Fowler & Boppana, 2006; Staras, Dollard, & 
Radford, 2006).
Nonetheless, CMV has a very heavy disability burden 
when acquired congenitally. It is the leading cause of 
non-genetic hearing loss (Fowler & Boppana, 2006) with 
15–20% of bilateral moderate to profound sensorineural 
hearing loss caused by CMV (Grosse, Ross, & Dollard, 
2008). Congenital CMV also causes mental retardation, 
cerebral palsy, and many other disabilities (Dollard, Grosse, 
& Ross, 2007). Approximately 0.7% of infants are estimated 
to be born with congenital CMV in the United States, 
leading to 30,000 annual cases. About 90% of these babies 
are referred to as asymptomatic because there are no 
clinically apparent symptoms of the infection, and 10% 
are referred to as symptomatic because there are obvious 
clinical abnormalities (Boppana, Ross, & Fowler, 2013). 
Approximately 6,000, or one in five of those newborns 
with congenital infection will go on to develop permanent 
disabilities such as microcephaly, hearing loss, vision loss, 
cerebral palsy, seizure disorders, or cognitive impairment 
(Cannon, 2009). 
According to the Institute of Medicine (IOM, 2000), the cost 
of medical and educational care for children with disabilities 
known to be due to congenital CMV in the United States 
is $1.9 billion per year. Given such high costs associated 
with congenital CMV, the IOM identified the development 
of a vaccine to prevent congenital CMV as a top priority. 
However, a vaccine appears to be years, if not decades 
away (Adler & Nigro, 2013).
There is no FDA-approved treatment for congenital CMV, 
but recent research by Kimberlin et al. (2015) on the use 
of Valganciclovir to treat symptomatic congenital CMV 
infections is promising. Even if an approved treatment or a 
vaccine can be developed and becomes widely available, 
the best alternative for reducing the incidence of congenital 
CMV at the present time appears to be more widespread 
use of basic hygiene practices among pregnant women to 
avoid transmission via saliva or urine from young children 
(Adler & Nigro, 2013; Pass & Anderson, 2014; Swanson 
& Schleiss, 2013). The first step in improving hygiene 
practices that will likely lead to reducing the incidence 
of congenital CMV, is ensuring that the general public, 
especially men and women of childbearing age, knows 
about the existence and consequences of CMV.
This paper presents previously unpublished findings from 
the 2015 and 2016 HealthStylesTM surveys about the 
awareness of CMV among adults in the United States. It 
uses the results of analyses to identify further research 
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needs and guidance for policymakers and public health 
programs on where to focus efforts to increase awareness 
of congenital CMV.
CMV Transmission
Pregnant women are most likely to contract CMV from 
young children and intimate partners (Fowler & Pass, 
2006). CMV is transmitted from young children to pregnant 
women through urine or saliva during diaper changes, 
sharing of eating utensils, or exchanging saliva when 
kissing. CMV can also be sexually transmitted. 
Johnson, Anderson, and Pass (2012) documented 
a number of factors associated with acquisition of 
CMV infections, often referred to in the literature as 
seroconversion. Seroconversion is when a person 
transitions from seronegative (has never had a CMV 
infection) to seropositive or seroconverted (has had a CMV 
infection). Low income pregnant women have almost three 
times the incidence (6.8%) of CMV infection compared 
to middle income pregnant women (2.5%). Thirty-seven 
percent of women in sexually transmitted disease (STD) 
clinics and 7.9–10% of daycare workers contract CMV 
infections each year. At the highest risk for CMV infection 
are parents of children who have recently had an active 
CMV infection and have CMV in their saliva, urine, and 
other bodily fluids that could be passed to another person 
(often referred to as shedding the virus). 
CMV Prevention
Stowell, et al. (2014) found that while the CMV virus 
can live for up to 15 minutes on hard plastic and up to 5 
minutes on crackers, no viable virus was recovered after 
washing hands with soap, sanitizer, or even just with water. 
The Centers for Disease Control and Prevention (CDC) 
recommend that an effective way of reducing exposure 
to and the incidence of CMV infection is by “regular hand 
washing, particularly after changing diapers.” (CDC, n.d.). 
Research studies have demonstrated that this and other 
preventative steps are effective. For example, Adler and 
Nigro (2013) found that only 3% (one of 37) of CMV-
seronegative pregnant women with an infected young child 
who were educated about using simple hygiene practices 
in their daily routines seroconverted to CMV during 
pregnancy, while 42% (65 of 154 women) of pregnant 
women who were not educated seroconverted. 
Other studies support the implementation of preventative 
hygienic precautions. Revello et al. (2015) found that 
only 1.2% of women who were given hygiene information 
and prospectively tested until delivery acquired a CMV 
infection, compared to 7.6% in a comparison group that 
were neither tested nor informed about CMV during 
pregnancy. Importantly, 93% of these women felt hygiene 
recommendations were worth suggesting to all pregnant 
women at risk for infection. In an earlier study, Vauloup-
Fellous et al. (2009) found, for 2,595 seronegative 
women, that the incidence of maternal CMV conversion 
was reduced from 0.035% per woman-week to 0.008% 
per woman-week (P = .0005) following an educational 
intervention. Women were less than 25% as likely to 
acquire a CMV infection when the woman and her partner 
were given detailed information on preventative hygienic 
measures verbally and in writing. 
Previous Assessments of CMV Awareness
The public health impact of congenital CMV infection is 
substantial and under-recognized. (Swanson & Schleiss, 
2013). While congenital CMV is one of the most common 
causes of congenitally acquired childhood disabilities and is 
preventable, most women of childbearing age have never 
heard of it (Cannon, 2009; Jeon et al., 2006; Ross, Victor, 
Sumartojo, & Cannon, 2008). 
Three surveys of public CMV awareness in the United 
States have been conducted in the past decade. Jeon 
et al. (2006) surveyed 643 women at seven geographic 
locations (Atlanta, GA; Birmingham, AL; Cleveland, OH; 
Provo, UT; Richmond, VA; Chicago, IL; and Houston, TX) 
and found that only 142, or 22%, of women surveyed had 
heard of congenital CMV. Women’s awareness statistically 
significantly increased with higher levels of education, older 
age, and previous employment in a healthcare profession. 
When multiple regression analyses were used to adjust for 
other covariates, age no longer predicted awareness, but 
higher levels of education (high-school diploma or less, 
OR = 1.0; some college, OR = 1.5; bachelor’s degree or 
more, OR = 2.1; p = .03) and employment in a healthcare 
profession (no, OR = 1.0; yes, OR = 6.8, p < .0001) 
remained statistically significantly related. The study found 
no statistically significant differences by income, race and 
ethnicity, or between women who had been pregnant and 
who had never been pregnant. The study also found that 
employment in a daycare setting did not impact awareness 
(no, 21%, OR = 1.0; yes, 27%, OR = 1.4; p = .18).
Jeon et al. (2006) also found that most women, even those 
who had heard of CMV, could not identify modes of CMV 
transmission or prevention and 23% (83 of 137) incorrectly 
stated that CMV could be prevented by avoiding cat litter. 
One strength of the study was that it compared awareness 
about CMV with awareness about other birth defects 
and childhood illnesses and first reported the disparity 
between awareness and incidence rates of various 
childhood conditions. Jeon et al. (2006) noted that 53% of 
respondents were aware of congenital rubella syndrome, 
which had been eradicated in the United States, compared 
to 22% who were aware of CMV.  Comparing CMV 
awareness with other diseases and conditions provides 
context for the results and makes them more relevant for 
decision- and policymakers.
A limitation of Jeon et al.’s (2006) study was that 
participants were recruited from pediatric outpatient clinic 
waiting rooms (4 sites), an obstetrics/gynecology clinic, 
a university’s student center, and medical students and 
support staff in a hospital. The fact that the survey was a 
convenience sample administered in mainly healthcare 
settings means that it may not be representative of all 
women in the United States (for example, women with 
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knowledge about CMV were likely oversampled given that 
the survey was conducted in health care settings).
Awareness of congenital CMV was also queried in the 2005 
and 2010 HealthStylesTM survey, a subset of a consumer 
mail survey of U.S. adults over 18 years of age commonly 
used by the CDC for public health planning (Ross et 
al., 2008). HealthStylesTM surveys oversample certain 
demographic groups to enable more precise estimates 
about responses from people in those groups, but then 
the data are weighted to create a nationally representative 
sample with respect to age, sex, race/ethnicity, income, 
and household size. In the 2005 HealthStylesTM survey, 
2,656 females and 2,163 males responded to four CMV-
related questions, but the analyses reported by Ross et 
al. (2008) only focused on women because they are at 
risk for transmitting CMV to an unborn child. The potential 
role of a sexual partner in spreading CMV to a pregnant 
woman was not considered. Four questions asked whether 
participants had heard of CMV, where they learned about 
CMV, knowledge about the effects of CMV, and whether 
they would willingly adopt measures to prevent CMV while 
pregnant. The survey also collected demographic variables 
including sex, age, income, race and ethnicity, level of 
education, and household size.
Ross et al. (2008) reported that 14% of women had heard 
of CMV, and consistent with Jeon et al. (2006), knowledge 
increased with level of education (did not graduate high 
school, 10%, OR = 1.0; graduated high school, 6%, OR = 
0.6; attended college, 13%, OR = 1.4; graduated college, 
22%, OR = 2.6; 5–8 years of graduate school, 23%, OR = 
2.7; p < 0.001). Knowledge also increased with household 
income, but not when other covariates were controlled 
using multiple regression analyses.
Ross et al. (2008) also found that the preventative 
hygiene measures previously recommended by the CDC 
were judged to be easy to adopt by a large majority of 
participants, regardless of whether participants had heard 
of CMV. For example, 90% reported that washing hands 
would be very easy to adopt and 65% reported that it 
would be easy to adopt the recommendation to not share 
eating utensils with a young child. Fewer participants, 48%, 
reported that not kissing a young child on the mouth would 
be very easy, but 20% reported it would be somewhat easy. 
The 2010 HealthStylesTM survey, with a sample of 2,181 
women and 2,003 men, showed 13% of women and 7% of 
men had heard of CMV (Cannon et al., 2012). As with the 
2005 survey, Cannon et al. (2012) only reported analysis 
results for women. Congenital CMV awareness varied by 
age, race/ethnicity, educational attainment, geographic 
region, and household income, with the strongest 
association between CMV awareness and the educational 
level of the respondent, even though awareness among 
women with post-graduate education was only 21%. 
Because only linear trend data were reported, odds 
ratios cannot be compared to previous surveys. The 
2010 survey did not repeat questions related to the ease 
of implementing the CDC’s recommended precautions, 
but added questions regarding the number of times 
women with children under age 19 engaged in risk and 
preventative behaviors while their youngest child was still 
in diapers. The study found that both risk and preventative 
behaviors are common (e.g., 69% of women reported 
kissing young children on the lips, 42% reported sharing 
utensils with young children, 95% reported washing hands 
after diaper changing, and 65% reported washing hands 
after wiping a child’s nose).
Recently, Thackeray and Magnusson (2016) assessed 
childcare provider awareness of CMV and other infectious 
diseases by asking a random sample of licensed family 
and residential childcare providers in Utah to complete a 
29-item questionnaire on awareness of CMV and other 
infectious diseases. The study focused on awareness 
as well as knowledge of how to prevent diseases in 
childcare settings. Thackeray and Magnusson found that 
18.5% of 306 respondent childcare providers had heard 
of CMV. For comparison, 99.4% were aware of influenza, 
67.2% of giardia, 24.9% of toxoplasmosis, and 23.2% of 
enterovirus. Because childcare providers are at higher risk 
for CMV infections and may be serving infants and young 
children with asymptomatic CMV infections, it is particularly 
important that they are aware of CMV (Thackeray & 
Magnusson, 2015). While targeted information has been 
provided to licensed childcare providers in Utah (Utah 
Department of Health, n.d.), public awareness efforts 
should reach both licensed and unlicensed childcare 
providers everywhere.
Finally, a 2014 survey of congenital CMV knowledge 
among medical students (Baer, McBride, Caviness & 
Demmler-Harrision, 2014) found that 34% of first year 
medical students and 100% of second through fourth year 
medical students at Baylor University, were somewhat 
or very familiar with CMV. Self-reported awareness by 
these students who were enrolled at a university with a 
history of significant research conducted on congenital 
CMV, was confirmed based on second through fourth year 
students’ knowledge of modes of CMV transmission and 
signs and symptoms of CMV. Similar studies have not 
been conducted at other institutions where CMV research 
is not a priority. Consistent with results from the 2005 
HealthStylesTM survey of CMV awareness completed by 
the CDC showing correlation with employment in a medical 
field, students’ awareness in this study was strongly 
correlated with level of medical education (p <.0001).
In summary, CMV awareness among the general 
population is low and appears to be declining over time. 
While there are some predictors of CMV awareness, even 
those factors only raise CMV awareness levels among the 
general population slightly. This article uses data from more 
recent HealthStylesTM surveys to evaluate whether CMV 
awareness rates are declining and discusses potential 
research and public health policy mechanisms that could 
be used to increase awareness about CMV.
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syndrome, autism, spina bifida, congenital toxoplasmosis, 
and parvovirus B19? The resulting data were provided to 
Utah State University for analysis. Both data sets were 
collected by Porter Novelli Public Services via GfK’s 
KnowledgePanel® (a national, probability-based panel 
that is representative of the entire U.S. population). GfK’s 
KnowledgePanel® consists of 55,000 panel members who 
are randomly recruited from a sample frame of residential 
addresses “including households that: have unlisted 
telephone numbers, do not have landline telephones, are 
cell phone only, do not have current internet access, and do 
not have devices to access the internet” (GfK, 2013). GfK 
provides household without phone and or internet with a 
laptop computer and internet access. The panel of 55,000 
is continuously replenished and respondents for individual 
surveys are selected from the larger panel to ensure a 
representative sample.
The summer 2015 HealthStylesTM survey was conducted 
from June 11 to June 29, 2015 with 4,127 adults completing 
the survey (a response rate of 67%). All respondents 
received compensation for completing the survey in the 
form of cash-equivalent reward points worth approximately 
$10. Respondents with incomplete responses (who did not 
answer at least half of the questions, n = 7) and speeders 
(who completed the survey in 7 minutes or less, n = 33) 
were removed from the data.
The summer 2016 survey was conducted from June 24 
to July 11, 2016 using the same procedures and had a 
response rate of 68% with 4,203 of 6,166 adults completing 
the survey. Participants received the same compensation 
as that provided in 2015. Incomplete (n = 10) and speeder 
(n = 39) responses were removed from the data set.
Participants responded to a question asking if they had 
heard of the following conditions: congenital rubella 
syndrome, beta strep (Group B strep), HIV/AIDS, 
congenital cytomegalovirus (CMV), Down syndrome, 
sudden infant death syndrome (SIDS), fetal alcohol 
syndrome, autism, spina bifida, congenital toxoplasmosis, 
and parvovirus B19. The question asked for each condition 
was “Have you heard of [condition]?”. Response choices 
were Yes, No, or the participant could refuse to answer the 
question. Respondents’ awareness of CMV compared to 
awareness of other conditions provides context to policy 
and decision makers and allows for analysis of awareness 
compared to disease burden, making a case for the 
potential impact of CMV awareness initiatives.
Data were also available about each respondent’s race/
ethnicity, gender, zip code, whether the respondent 
currently had children under age 18, ages of the 
respondent’s three youngest children, age, education 
(highest degree received and categorical), household size, 
household income, marital status, metro status (metro or 
non-metro), census region, employment status, housing 
status (own, rent, or occupied without payment of rent), and 
state of residence. Weights were provided so that survey 
responses could be matched to U.S. Current Population 
CMV Awareness Programs
Recently, there have been a number of public health 
efforts to increase awareness about CMV. In 2013, the 
Utah Legislature unanimously passed the first CMV public 
health initiative law (McVicar, 2014). Utah’s law mandates 
that the Utah Department of Health implement a public 
health education campaign to inform women who are 
pregnant or might become pregnant about CMV, the risks 
associated with CMV, and the recommended prevention 
measures. The law also mandates an education campaign 
for medical and child-care professionals. The charge for 
implementation was given to the Early Hearing Detection 
and Intervention (EHDI) program within the state’s 
Department of Health.
Utah’s law was the first of its kind and appears to have 
spurred action in several other states. As of 2015, five 
states had enacted CMV laws (Doutre, 2015). Based on 
enactment of these laws, multiple programs have been 
initiated by state Departments of Health to educate women 
about CMV. In addition to legislatively-mandated public 
awareness programs, other EHDI programs are leading 
efforts to raise awareness of CMV (Mirizzi et al, 2015).
A number of non-profit organizations are also working to 
raise awareness of CMV. The National CMV Foundation 
(2015) was founded when four non-profit CMV 
organizations joined forces with an aim to “empower 
women, parents, families, and local community networks 
through grassroots engagement to facilitate conversations 
about CMV and to champion the cause against congenital 
CMV” (http://www.nationalcmv.org).
As public health programs and non-profit organizations 
work to increase awareness about CMV, it is important to 
document how people’s awareness of CMV is changing. 
Such efforts will help focus educational efforts, identify 
factors that influence likelihood of CMV awareness, 
evaluate effectiveness of approaches to increasing CMV 
awareness, and determine areas of need and opportunity 
for the greatest impact. This article combines results from 
the previously-reported 2005 and 2010 HealthStylesTM 
survey data (Ross et al., 2008; Cannon et al., 2012) with 
previously unreported analyses from the 2015 and 2016 
HealthStylesTM survey data to examine whether public 




The National CMV Foundation contracted with Porter 
Novelli to include the same awareness question about CMV 
in the 2015 and 2016 Summer HealthStylesTM  surveys 
that had been asked in the 2005 and 2010 versions of 
the survey. Have you heard of the following: congenital 
rubella syndrome, beta strep (Group B strep), HIV/AIDS, 
congenital cytomegalovirus (CMV), Down syndrome, 
sudden infant death syndrome (SIDS), fetal alcohol 
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Survey proportions using 9 factors: gender, age, household 
income, race/ethnicity, household size, education, census 
region, metro status, and prior internet access.
Data Analysis
An analysis of descriptive statistics was conducted for all 
study variables for both the 2015 and 2016 HealthStylesTM 
data using the R statistical software program. Rates of 
awareness for CMV were computed using data weighted 
for representativeness and stratified by demographic 
characteristics. In addition, CMV awareness rates were 
compared to awareness rates for other conditions queried 
in the survey.
A total of five logistic regression models were used to 
assess both the trend and characteristics related to CMV 
awareness.  One model tests the trend across time, 
using the year as the independent variable. Two logistic 
regression models per year were used to determine 
the association of demographic conditions with CMV 
awareness, where CMV awareness was the binary 
outcome for both models. The first model examined basic 
demographic predictor variables: age, race, gender, 
education, and household income. The second model 
added two additional predictor variables to the model 
to examine parenthood and age of children: household 
presence of children under ages 0–1 and household 
presence of children ages 2–5. These variables were 
chosen based on the relativity of CMV awareness to 
families experiencing pregnancy and the increased risk of 
acquiring CMV from a young child.
Results 
The 2015 and 2016 HealthStylesTM CMV awareness rates 
are 6.79% and 6.70% in the overall U.S. population when 
weighted for representativeness. Awareness rates for 
all levels of the various demographic characteristics are 
similarly low as shown in Table 1. Females have a higher 
rate of awareness than males (9.08% and 9.17% in 2015 
and 2016 compared to 5.72% and 4.92%), but the number 
of females reporting awareness of congenital CMV has 
decreased from 14% and 13% in 2005 and 2010. Figure 
1 is a summary of HealthStylesTM survey data from 2005, 
2010, 2015 and 2016, showing a decrease over 11 years 
for women from 14% to 9% and for men a decrease from 
2010 to 2016 from 7% to 5%. Data from the 2005 survey 
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Table 1. U.S. Congenital Cytomegalovirus Awareness By Demographic Characteristics, 2015 and 2016
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A logistic regression analysis of awareness rates across 
years from 2005 – 2016 shows that the decrease in 
awareness among U.S. women is statistically significant 
(OR = 0.94, 95% CI = [0.93, 0.95], p < .0001). The lack of a 
combined rate reported in previous analyses does not allow 
for exploration of the statistical significance of the decline of 
overall awareness.
CMV awareness was compared to awareness of 
other congenital conditions associated with negative 
developmental outcomes, up to and including death. 
Respondents are least aware of CMV compared to the 
10 other conditions. Table 2 presents 2015 and 2016 
awareness rates of the 10 comparable conditions to 
congenital CMV and the estimated annual frequency, in 
number of congenital or infant cases that result in long-term 
disabilities for each condition. Figure 2 shows the disparity 
between awareness using 2016 results and frequency 
of the 11 surveyed conditions. Although other diseases 
with low awareness have relatively low occurrences, the 
difference between CMV’s relatively high occurrence and 
its low awareness is contrasted with Down syndrome, 
which has a similar occurrence rate (6,000 babies born 
with Down syndrome each year) but 85% to 89% report 
awareness of Down syndrome compared to 7% awareness 
for CMV.
Table 3 presents the results of each multivariate logistic 
regression model, reported as adjusted odds ratios (i.e., 
each odds ratio has been statistically adjusted for all other 
variables in the model), and their confidence intervals. In 
the first model, which included basic demographic predictor 
variables (age, race, gender, education, and household 
income), both gender and education level are statistically 
significant predictors of CMV awareness. In that model, 
women had an odds of awareness of one and a half to 
two times greater than men (2015: AOR = 1.56, 95% CI = 
[1.22, 2.00], p < .001; 2016: AOR = 1.94, 95% CI = [1.52, 
2.51], p < .001) and Hispanic adults (men and women) 
were less than half as likely to be aware of CMV as white 
adults (2015: AOR = 0.37, 95% CI = [0.19, 0.67], p < .001). 
Education also was statistically significantly associated 
with awareness about CMV. For each increase in unit of 
education, the odds of awareness increased by 1.5 times 
(2015: AOR = 1.50, 95% CI = [1.29, 1.74], p < .001; 2016: 
AOR = 1.43, 95% CI = [1.23, 1.66], p < .001).
The second model included the presence of children 
ages 0–1 or ages 2–5 in the household, which was used 
as an indicator of whether the household had recently 
experienced a pregnancy. Adding these factors did not 
change the relationships seen in Model 1 for either year.  
Further, the additional variables (the presence of household 
members ages 0–1 or ages 2–5) does not statistically 
































Figure 1.  Percentage of participants in the 2005–2016 HealthStylesTM surveys who reported they had heard of 





Beta Strep (Group B Strep)
Parvovirus B19 (Fifth Disease)
Fetal Alcohol Syndrome
Spina Bifida












































Note. Awareness data taken from the 2015 and 2016 HealthStylesTM surveys. 
a Approximate frequency of infants affected with long-term disabilities, including death, by each condition. b Cannon, M. J. 
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Figure 2. U.S. adult awareness of childhood conditions from the 2016 HealthStylesTM surveys with approximate 
annual U.S. incidence of disability due to each condition.
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Table 3 presents the results of each multivariate logistic 
regression model, reported as adjusted odds ratios (i.e., 
each odds ratio has been statistically adjusted for all other 
variables in the model), and their confidence intervals. In 
the first model, which included basic demographic predictor 
variables (age, race, gender, education, and household 
income), both gender and education level are statistically 
significant predictors of CMV awareness. In that model, 
women had an odds of awareness of one and a half to 
two times greater than men (2015: AOR = 1.56, 95% CI = 
[1.22, 2.00], p < .001; 2016: AOR = 1.94, 95% CI = [1.52, 
2.51], p < .001) and Hispanic adults (men and women) 
were less than half as likely to be aware of CMV as white 
adults (2015: AOR = 0.37, 95% CI = [0.19, 0.67], p < .001). 
Education also was statistically significantly associated 
with awareness about CMV. For each increase in unit of 
education, the odds of awareness increased by 1.5 times 
(2015: AOR = 1.50, 95% CI = [1.29, 1.74], p < .001; 2016: 
AOR = 1.43, 95% CI = [1.23, 1.66], p < .001).
The second model included the presence of children 
ages 0–1 or ages 2–5 in the household, which was used 
as an indicator of whether the household had recently 
experienced a pregnancy. Adding these factors did not 
change the relationships seen in Model 1 for either year.  
Further, the additional variables (the presence of household 
members ages 0–1 or ages 2–5) does not statistically 
significantly predict CMV awareness.
Discussion 
Awareness of congenital CMV decreased by nearly 50% 
from 2010 to 2015 and 2016 despite the large disease 
burden and high frequency of infections. The 2015 and 
2016 HealthStylesTM survey data showed lower awareness 
rates despite increased attention to congenital CMV in the 
public health and policy arenas. It is noteworthy that CMV 
awareness is even lower than congenital rubella syndrome, 
which has been eradicated, and lower than other less 
common conditions. Most of the documented efforts by 
public health entities to increase CMV awareness (e.g., 
Doutre, 2015; Mirizzi et al., 2015) have taken place since 
2013 so it may be too early to see the impact of those 
activities, but the fact that CMV awareness appears to be 
declining is a serious concern.
Consistent with previous research, analyses of the 
HealthStylesTM survey data across multiple years showed 
that women are more likely to be aware of CMV than men. 
This difference is expected as congenital CMV is most 
relevant to pregnant women but the odds ratios of 1.56 
(2015) and 1.94 (2016) are lower than desirable in order 
to promote prevention of transmission from mother to 
fetus during pregnancy. These data suggest that women’s 
doctors may not be counseling them on CMV despite its 
prevalence and the associated disability burden.
The significance of the differences by demographic factor 
are further explored in the logistic regression models. In 
addition to CMV awareness being higher among women 
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in 2015 and 2016 than for men, CMV also varied by race/
ethnicity. Adult respondents reporting Hispanic ethnicity 
reported lower CMV awareness (2.92% in 2015 and 5.13% 
in 2016) than adults in general and adults reporting any 
other race or ethnicity category. If an adult currently has 
children under age 18 he or she is more likely to be aware 
of CMV, but awareness in this group remains low (10.23% 
in 2015 and 9.77% in 2016).
CMV awareness increases with increasing levels of 
education as reported in previous studies. The correlation 
of awareness with education level is concerning. Women 
with low socioeconomic status have almost three times the 
incidence of CMV infection compared to middle income 
pregnant women (Johnson et al., 2012) and it appears 
that awareness of CMV is often associated with higher 
education levels that may not be accessible to women of 
lower socioeconomic status. But, even in the most aware 
group (those with a professional or doctorate degree, 
n = 131), only 20% of the respondents to the 2015 and 
2016 HealthStylesTM surveys had heard of CMV. Public 
awareness and education initiatives are needed at all 
levels.
At the highest risk for CMV infection are parents of 
children who have recently had an active infection and are 
shedding the virus in bodily fluids (Johnson et al., 2012). 
The surrogate measures to this variable are the measures 
of adults who report the presence of children ages 0–1 or 
the presence of children ages 2–5 in their household. The 
presence of children of these ages in the household were 
not statistically significantly related to CMV awareness. A 
large majority of respondents, 89.5%, did not report having 
any children ages 0–1.
Conclusions 
Analyses of the 2015 and 2016 HealthStylesTM survey 
data shows that awareness of CMV is decreasing among 
adults in the United States. Because of the high burden 
of disease associated with congenital CMV, it is alarming 
that the virus is relatively unknown. There is good evidence 
that preventative hygienic measures taken by women and 
their partners can reduce the risk of CMV infection and 
thus the risk of transmitting CMV to a fetus (Adler and 
Nigro, 2013; Revello et al., 2015; Vauloup-Fellous et al., 
2009). A logical precursor to the wider implementation of 
preventative hygienic measures is increased awareness of 
CMV. Therefore, the decreasing trend in CMV awareness 
documented by the HealthStylesTM survey data from 2005 
to 2016 is of great concern.
CMV awareness is low for all subsets of the U.S. 
population, but it is especially low for Hispanic adults. 
Even though awareness is higher for women and those 
with higher education levels, awareness in those groups 
remains alarmingly low considering CMV’s disease burden 
and incidence rate. Furthermore, because CMV can be 
transmitted through sexual relations, it is important for men 
to be aware of what CMV is and how to prevent it.
The fact that CMV awareness is so low and is decreasing 
will hopefully help public health policymakers and program 
officials prioritize and focus their efforts to increase CMV 
awareness and prevention efforts. The data from the 
HealthStylesTM surveys also provide baseline data for 
beginning to evaluate CMV public health programs and 
specific initiatives, whether mandated by legislation or 
prioritized by stakeholders. Continued resources must be 
dedicated to increase awareness and prevention of this 
harmful virus.
Limitations
The greatest limitation of this study is the narrow definition 
of CMV awareness. Survey respondents responded to 
one yes/no question: “Have you ever heard of congenital 
cytomegalovirus (CMV)?” Ideally, additional questions 
would be asked to validate respondents’ awareness of 
CMV, such as how CMV is acquired, what the symptoms 
of CMV are, what measures may be taken to prevent 
CMV, or if there is a CMV vaccine available. Reponses 
to these questions would allow policy makers and public 
health officials to better target their efforts to increase CMV 
awareness and prevention initiatives.
Another limitation of this study was the inability to evaluate 
CMV awareness by state and set a baseline for CMV 
awareness for states working to increase CMV awareness. 
Although state data were provided for each participant, 
sample sizes from most states were too small to establish 
awareness rates by state. These data would be useful in 
planning for CMV awareness programs.
Implications for Further Research
Although the data collected through the HealthStylesTM 
survey are useful in establishing the need for CMV 
awareness campaigns and education, further research is 
needed in many areas related to CMV awareness. First, no 
reported research has been conducted on the efficacy of 
different methods of raising public awareness and whether 
raising awareness of CMV leads to behavior changes in 
pregnant women.
Research has established the reasonableness and efficacy 
of recommended hygienic measures for reducing risk of 
acquiring a CMV infection during pregnancy (Adler and 
Nigro, 2013; Revello et al., 2015; Vauloup-Fellous et al., 
2009). However, further research is needed on how to 
best educate women about hygienic practices and when is 
most appropriate. For example, it would be useful to know 
if high school health education programs can effectively 
reach women who are just reaching child-bearing age. The 
correlation between education level and CMV awareness 
suggests a need for further research to study public health 
programs including those for high school students and 
other young adults. It would be useful to examine high 
school and undergraduate health education curriculum 
to determine whether information about CMV is currently 
included. In addition, further research should be conducted 
to determine whether health care providers are informing 
women planning to become pregnant and their sexual 
partners of CMV.
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Implications for Policy and Public Health Programs
As state EHDI programs, other state agencies, and 
non-profit organizations embark on public awareness 
programs, consideration should be given to the fact that 
CMV awareness seems to be declining. There is a great 
need for general awareness and all populations are in 
need of education about congenital CMV including low 
socioeconomic and Hispanic populations. Consideration 
should be given to educating young adults at the beginning 
of their childbearing age. Programs should also ensure that 
educational materials are available to adults of all races 
and ethnicities, especially those with Hispanic ethnicity.
Although women are more likely than men to know about 
congenital CMV, it should be the goal of public education 
campaigns to raise awareness of both men and women. 
Because CMV can be spread through sexual activity 
(Fowler & Boppana, 2006; Staras et al., 2006), men should 
also be aware of and exercise hygienic precautions during 
a partner’s pregnancy to reduce the risk of obtaining a CMV 
infection.
CMV awareness rates are alarmingly low and there is a 
significant need for CMV education programs. As more 
states and other organizations pursue CMV awareness 
programs, further work will be needed to establish 
measures of the effectiveness of the public health and 
policy actions related to CMV. More detailed data, with 
larger sample sizes on a local scale, are needed to 
evaluate efforts of state stakeholders and non-profit 
organizations in developing policy and public information 
programs for CMV.
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